Home / Platform
MICS™ Minimally Invasive Cochlear System
MICS delivers our local formulations to the inner ear, with each formulation matched to its drug substance.Designed for the ENT office, not the operating room.
Precise delivery, in the clinic
Until now, physicians had to choose between delivering a drug blind in the clinic or precisely in the operating room. MICS brings precise delivery into the clinic.
Office injection
Performed blind. The physician cannot confirm where the drug ends up.
- Precise placement No
- Performed in the clinic Yes
Surgery
Precise placement, but it requires an operating room.
- Precise placement Yes
- Performed in the clinic No
MICS™
Precise placement of our local formulations under direct visualization, in a routine office visit.
- Precise placement Yes
- Performed in the clinic Yes
One system across drug classes
MICS places the right drug at the right target. Each drug substance is paired with a formulation suited to it, so the same system works with small molecules, proteins and advanced therapies.
MICS™ + formulations tailored to each drug
Small molecules
Formulations of approved and novel agents, including our most advanced program.
SPT-2101 · SPT-5108Proteins
Neurotrophins and other biologics, where formulation and local exposure are the bottleneck.
SPT-4106Advanced therapies
Gene and cell therapies, where precise delivery matters most.
In evaluationAccess is what has held the field back
The biology of inner ear disease is better understood than ever, and promising molecules exist. What has been missing is a reliable way to place enough drug at the inner ear. MICS and our local formulations are designed to address that, so more inner ear therapies can reach patients.
See our pipeline